**Author details**

Mayara Ingrid Sousa Lima1 \*, Emilly Caroline dos Santos Moraes2 , Jaqueline Diniz Pinho3 , Gustavo Henrique Corrêa Soares4 and Ítalo Vinícius Cantanhêde Santos1

[9] Cabral E, Junior C, Alexandre C, Alexandre A, Thially B, Tereza C.Anti-PGL1 salivary IgA/ IgM, serum IgG/IgM, and nasal *Mycobacterium leprae* DNA in individuals with household contact with leprosy. International Journal of Infectious Diseases. 2013;**17**(11):1005-1010.

Molecular and Biotechnological Approaches in the Diagnosis of Leprosy

http://dx.doi.org/10.5772/intechopen.75506

73

[10] Hussain R, Shahid F, Zafar S, Dojki M, Dockrell M. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of *Mycobacterium leprae* and *M. tuberculosis* GroES in a BCG vaccinated area: Implications for development of vaccine and diagnostic reagents. Immunology. 2004;**111**(4):462-471. DOI: 10.1111/j.0019-2805.2004.01839.x

[11] Lobato J, Costa P, Reis E, Gonçalves A, Spencer J, Brennan J. Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection. Leprosy Review.

[12] Hartskeerl A, De Wit Y, Klatser R. Polymerase chain reaction for the detection of *Mycobacterium leprae*. Journal of General Micorbiology. 1989;**135**(9):2357-2364. DOI: 10.1099/

[13] Azevedo C, Ramuno M, Fachin R, Tassa M, Rosa S, Belone F. qPCR detection of *Mycobacterium leprae* in biopsies and slit skin smear of different leprosy clinical forms. The Brazilian Journal of Infectious Diseases. 2017;**21**(1):71-78. DOI: 10.1016/j.bjid.2016.09.017

[14] Araujo S, Goulart R, Truman W, Goulart B, Vissa V, Li W. qPCR-high resolution melt analysis for drug susceptibility testing of *Mycobacterium leprae* directly from clinical specimens of leprosy patients. PLoS Neglected Tropical Diseases. 2017;**11**(6):e0005506.

[15] Nath I, Saini C, Valluri L. Immunology of leprosy and diagnostic challenge. Clinical

[16] Martelli T, Stefani A, Penna O, Andrade S. Endemias e epidemias brasileiras, desafios e perspectivas de investigação científica: hanseníase. Revista Brasileira de Epidemiologia.

[17] BRAZIL. Ministry of Health. Guide to Technical Procedures Bacilloscopy in Leprosy.

[18] Stretch R. Presentation and treatment of Hansen's disease. Nursing Times. 1999;**95**(29):

[19] ARAUJO G. Hanseníase no Brasil. Revista da Sociedade Brasileira de Medicina Tropical.

[20] BRAZIL.Ministry of Health. Secretariat of Health Policies. Department of Basic Attention. Technical Area of Sanitary Dermatology. Legislation on the Control of Leprosy in Brazil.

[21] Leiker DL, McDougall AC. Guia técnico baciloscopia da hanseníase. 2nd ed. Wurzburg:

Dermatology. 2015;**33**(1):90-98. DOI: 10.1016/j.clindermatol.2014.07.005

2002;**5**(3):220-225. DOI: 10.1590/S1415-790X2002000300006

DOI: 10.1016/j.ijid.2013.05.011

2011;**82**(4):389-401

00221287-135-9-2357

Brasília; 2010

2003;**36**(3):373-382

DAHW; 1987

Brasília: Ministry of Health; 2002

46-47

DOI: 10.1371/journal.pntd.0005506

\*Address all correspondence to: mayaingrid@yahoo.com.br

1 Department of Biology, Federal University of Maranhão, São Luís, Maranhão

2 Postgraduate Program in Health of Science, Federal University of Maranhão, São Luís, Maranhão

3 Nucleus of Research in Oncology/HUJBB, Federal University of Para, Belém, Pará

4 Laboratory of Genetics and Molecular Biology, Department of Biology, Federal University of Maranhão, São Luís, Maranhão
